InvestorsHub Logo
Followers 99
Posts 17493
Boards Moderated 6
Alias Born 07/02/2009

Re: None

Wednesday, 08/11/2010 10:42:48 AM

Wednesday, August 11, 2010 10:42:48 AM

Post# of 400
Pfitzer has had some trials for eplerenone, and the benifits were so remarkable, cancelled further enrollment. Intrem findings had shown huge percentage of patients recieving the drug Vs placebo had improvements. (Eplerenone is safer, cleaner than Spironolactone used in similar therapys.)

http://www.theheart.org/article/1083009.do

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.